Scientific Reports · 2022 · 11 citations · 23 references
MedicineOncologyPathologyDiagnostic ImagingNeoplasiaUltrasonographyThyroid CancerThyroid CytologyThyroid ImagingThyroid Nodule EvaluationThyroid UltrasonographyThyroid UltrasoundBraf V600 MutationsBraf V600e MutationCytological FeaturesMultiple RegressionPreoperative DiagnosisThyroid Imaging Reporting And Data SystemsThyroid Nodule Classification SystemsThyroid Nodule Cytology
Abstract Fine needle aspiration biopsy is a crucial method for preoperative diagnosis of thyroid nodules. However, thyroid nodules classified as Bethesda categories III–V cannot obtain definite cytological results. Our aim was to study the diagnostic value of thyroid imaging reporting and data system combined with BRAF V600E mutation analysis in Bethesda categories III–V thyroid nodules, so as to provide more precise direction for the follow-up treatments. A total of 174 Bethesda categories III–V thyroid nodules performed TIRADS and BRAF V600E mutation analysis were included in the study. We retrospectively analyzed the ultrasound features as well as the results of BRAF V600E mutation of the 174 thyroid nodules. In the multiple regression analysis models, ultrasound features including lobulated or irregular margin, punctate echogenic foci, and shape with taller-than-wide were statistically significant in malignant nodules ( p < 0.05). The area under the curve of the combination of TIRADS and BRAF V600E increased to 0.925, which were much higher than TIRADS (0.861) and BRAF V600E (0.804) separately. Combined diagnosis was of the greatest value to identify Bethesda III–V thyroid nodules definitely, especially with higher sensitivity (93%) and accuracy (90%).
23
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John Tate, Sally Bamford, Harry Jubb et al. · Nucleic Acids Research · 2018 · 5.3K citations · Full text
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim, Susan S. Devesa, Julie Ann Sosa et al. · JAMA · 2017 · 2.2K citations · Full text
Medicine, Endocrinology, Oncology +17